7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Women's Health

How Often You Need a Smear Test (UK, EU and US Intervals)

20 min read
How Often You Need a Smear Test (UK, EU and US Intervals)

Key Takeaways

  • England moved to five-yearly cervical screening in July 2025 for 25- to 49-year-olds who test HPV-negative, matching the intervals already used in Scotland and Wales.
  • US guidelines start Pap testing at 21, three-yearly until 29, then offer a choice from 30 to 65: a Pap every three years, or an HPV test or co-test every five.
  • A negative HPV test justifies a five-year gap because cervical cancer typically takes 15 to 20 years to develop from persistent infection, per the WHO.
  • An HPV-positive result with normal cells doesn't mean treatment: it means a 12-month recall on the NHS, since most infections clear on their own.
  • HPV vaccination lowers risk substantially but doesn't cover every high-risk virus type, so vaccinated people follow the same screening schedule as everyone else.
  • Bleeding after sex, between periods, or after menopause needs a doctor's appointment now, screening intervals only apply to people with no symptoms.
Quick Answer

In the UK, cervical screening (a smear test) is offered every five years between ages 25 and 64, with earlier recall if HPV is found. In the US, guidelines suggest a Pap test every three years from 21 to 29, then a Pap, HPV test, or both every three to five years until 65. Most EU programs now invite people every five years.

A group chat, three friends, three countries. The one in Manchester gets a letter every five years and grumbles about it. The one in Boston books a Pap test every three years and assumes everyone does. The one in Amsterdam does a test at 30, then hears nothing for half a decade, and wonders if she’s been forgotten.

None of them is wrong, and none has been forgotten. Cervical screening schedules genuinely differ between the UK, the US and continental Europe, and they have shifted meaningfully in the past few years as HPV testing replaced the microscope-first approach most of us grew up with.

The result is a lot of confusion, and confusion is a real problem here, because in this test, showing up is nearly everything. So here is what each system actually asks of you, why the gaps have grown longer, and when the calendar should be ignored entirely.

What does a smear test actually check for?

A smear test, called a Pap smear in the US and cervical screening on the NHS, is a check for people with no symptoms. A clinician uses a soft brush to collect cells from the cervix, the neck of the womb, in a procedure that typically takes a few minutes according to the Mayo Clinic.

What happens to that sample has changed. Traditionally, a lab examined the cells under a microscope for abnormal changes (cytology). Modern programs in the UK and much of Europe, and one of the options in the US, first test the sample for high-risk types of human papillomavirus, or HPV: the virus responsible for almost all cervical cancers, per the World Health Organization. Only if HPV is found does the lab go on to look at the cells themselves.

Two things the test is not: it is not an STI panel, and it does not screen for ovarian or womb cancer. It answers one question, is this cervix showing early warning signs?, and it answers it well. The WHO notes cervical cancer typically takes 15 to 20 years to develop from persistent HPV infection in people with normal immune systems, which is exactly why a periodic check works: there is a long, quiet window in which changes can be found and dealt with before they become dangerous.

How often do you need a smear test in the UK?

The NHS invites everyone with a cervix aged 25 to 64 for cervical screening, and the standard interval across the UK is now five years, as set out on the NHS cervical screening page.

That is a recent change for England. Scotland and Wales moved to five-yearly invitations first, after adopting HPV primary testing; England followed in July 2025, extending the interval for 25- to 49-year-olds who test negative for HPV from three years to five. Northern Ireland has also adopted HPV primary screening. So the old rule of thumb, every three years in your twenties and thirties, every five after 50, is now out of date for most of the UK.

The five-year gap only applies if HPV is not found in your sample. Test positive for HPV with no cell changes, and the NHS recalls you in 12 months to see whether the infection has cleared, which it usually does. Test positive with cell changes, and you’ll be referred for a closer look at the cervix (colposcopy) rather than put back on the routine list.

One practical detail worth knowing: your first invitation can arrive up to six months before your 25th birthday, and it’s fine to book as soon as it does. If a letter never comes, a moved house, an unregistered GP, you can simply contact a GP surgery and ask.

What are the smear test intervals in the US?

American guidance offers choices, which is either flexibility or homework depending on your temperament. According to the CDC, reflecting US Preventive Services Task Force recommendations, screening starts at 21 regardless of sexual history:

  • Ages 21 to 29: a Pap test every three years.
  • Ages 30 to 65: one of three routes: a Pap test every three years, a high-risk HPV test every five years, or a combined Pap-plus-HPV “co-test” every five years.

All three routes are considered effective; the five-year HPV-based options are longer because a negative HPV result is such a strong predictor of low risk. Some US professional bodies have proposed starting at 25 with an HPV test every five years as the preferred approach: a sign that American practice is drifting toward the model the UK and much of Europe already use, but the intervals above remain the mainstream framework your clinician will most likely follow.

Unlike the UK, the US has no national invitation letter. The schedule lives with you and your clinician, often folded into a routine well-woman visit. That makes it easier to lose track: if you can’t remember your last test or which type it was, ask the practice for your record rather than guessing, because the correct interval depends on which test you actually had.

How often is cervical screening across Europe?

There is no single European smear test schedule, screening is organized nationally, but the direction of travel is remarkably consistent. The WHO recommends HPV testing as the preferred screening method, performed every five to ten years starting at age 30 for the general population, and EU guidance has pushed member states toward organized, HPV-based programs along similar lines.

In practice, most Western European countries invite people somewhere between ages 25 or 30 and 60 to 65, at intervals of three to five years, with five becoming the norm wherever HPV primary testing has been adopted. The Netherlands, an early mover, tests five-yearly from 30 and can extend the gap further for older adults who test HPV-negative. Countries still using cytology-first screening tend to keep three-year intervals, because looking at cells under a microscope is less sensitive per round than testing for the virus, so it needs repeating more often.

If you’ve moved between European countries, expect the rhythm to change and don’t read anything sinister into it. A Spaniard arriving in Sweden, or a German settling in Ireland, will be slotted into the local program at the local interval. What matters is registering with a local doctor so the system knows you exist, organized programs can only invite the people on their lists.

Why did screening move from every 3 years to every 5?

Longer gaps sound like a cutback. They’re actually a mark of a better test.

Cytology, the classic Pap smear, looks for cell changes that have already happened. It’s good, but it can miss early changes on any single round, which is why it was repeated every three years: the schedule compensated for the test. HPV primary screening flips the logic. It looks for the cause rather than the consequence, detecting the high-risk virus types that, per the WHO, drive nearly all cervical cancers.

That matters because of timescales. The WHO notes it usually takes 15 to 20 years for cervical cancer to develop after persistent infection in someone with a normal immune system. If a sensitive test finds no high-risk HPV today, the chance of dangerous cell changes appearing within the next five years is very low, low enough that testing sooner adds anxiety and procedures without adding safety. The NHS made exactly this argument when England extended its interval, as reflected on the NHS screening page.

There’s a second benefit people rarely mention: fewer false alarms. HPV infections are extremely common and usually harmless; screening too often catches transient infections the immune system was about to clear anyway, leading to follow-up appointments and worry for changes that would have resolved on their own. The five-year HPV-based schedule is a deliberate balance, catch what matters, leave alone what doesn’t.

Smear test intervals at a glance: UK vs US vs EU

Here is the comparison the group chat actually needed. These are routine intervals for people with no symptoms and no recent abnormal results: a positive HPV test or cell changes always shortens the clock.

Region Ages screened Routine interval Primary test
UK (NHS) 25–64 Every 5 years (12-month recall if HPV found) HPV test first; cytology if positive
US, ages 21–29 From 21 Every 3 years Pap test (cytology)
US, ages 30–65 30–65 Every 3 years (Pap) or every 5 years (HPV or co-test) Pap, HPV, or both
EU (typical HPV-based program) ~30 to 60–65 Every 5 years HPV test first
WHO recommendation From 30 Every 5–10 years HPV test

Sources: NHS, CDC, WHO.

Notice the pattern hiding in the table: wherever HPV testing leads, the interval is five years or longer; wherever cytology leads, it’s three. The schedules look different, but they encode the same underlying biology. If your own history includes treated cell changes, a weakened immune system, or a recent HPV-positive result, none of these rows applies to you: your clinician sets a personal schedule instead.

When should you have your first smear test?

At 25 in the UK, at 21 in the US, and typically 25 to 30 across Europe, and the reason it isn’t earlier is worth understanding, because it reassures a lot of anxious twenty-year-olds.

HPV is the most common viral infection of the reproductive tract, and most sexually active people will encounter it at some point, according to the WHO. In teenagers and young adults, the immune system clears the vast majority of these infections: the CDC notes most HPV infections resolve on their own within about two years. Meanwhile, cervical cancer before 25 is rare. Screening earlier would mostly detect infections and minor cell changes destined to disappear, funneling young people into follow-up procedures with real downsides and little benefit. The starting ages aren’t arbitrary; they mark the point where finding something is more likely to mean something.

Two clarifications people search for constantly. First, the start age doesn’t move based on when you became sexually active, earlier activity doesn’t trigger earlier screening, and no sexual history yet doesn’t exempt you once you pass the threshold, though UK guidance notes risk is lower if you’ve never had any sexual contact. Second, if you have symptoms before your first invitation, abnormal bleeding, unusual discharge, that’s a doctor’s appointment, not an early smear test. Screening is for the symptom-free; symptoms get investigated properly at any age.

When can you stop having smear tests?

The NHS stops routine invitations at 64, per the NHS screening page. In the US, the CDC puts the exit at 65, but with an important condition: you can stop only if your recent screening history is adequate and negative. In US practice that generally means several consecutive normal results within the past decade, with the most recent test inside the last five years, and no history of significant cell changes.

That condition is the part people miss. Turning 65 with a twenty-year gap since your last test isn’t a graduation; it’s an overdue appointment. Cervical cancer risk doesn’t vanish at retirement age: a meaningful share of cases occur in people over 65, very often those who fell out of screening years earlier. If you’re approaching the cutoff and can’t confirm your history, one more test settles the question and may buy you a screening-free future.

Why stop at all? Because HPV acquired late in life is less common, changes progress slowly, and someone with decades of negative results carries a very low risk of developing cervical cancer in their remaining lifetime. Continuing to screen a low-risk 70-year-old produces more discomfort and false alarms than protection. As ever, individual history overrides the calendar: previously treated pre-cancerous changes usually mean continued surveillance beyond the standard stop age, on a schedule your clinician sets.

Do you still need smear tests after the HPV vaccine?

Yes, vaccinated people follow exactly the same screening schedule as everyone else. This surprises many people, and the logic deserves a plain explanation rather than a flat instruction.

HPV vaccines protect against the highest-risk virus types, and they do it impressively well when given before exposure. But there are more than a dozen high-risk HPV types, and no vaccine covers all of them, as the CDC notes in its screening guidance. Vaccination also can’t clear an HPV type you’d already encountered before your shots. So a vaccinated cervix is a much lower-risk cervix, not a zero-risk one.

Think of it as two layers of the same defense. Vaccination dramatically shrinks the pool of infections that could ever cause trouble; screening catches the rare exceptions early, in that long 15-to-20-year window the WHO describes between persistent infection and cancer. The WHO’s global elimination strategy explicitly relies on both layers working together, not either alone.

Will intervals eventually lengthen for vaccinated generations? Possibly. As cohorts vaccinated in their early teens move through their thirties and forties, researchers are studying whether their much lower HPV rates justify fewer lifetime tests. Some countries are actively modeling this. But that’s a decision for screening programs armed with population data, not something to decide for yourself by skipping invitations. For now, the letter still applies to you, jabs or no jabs.

Do you need smear tests after a hysterectomy?

It depends entirely on two questions: was the cervix removed, and why was the surgery done?

After a total hysterectomyremoval of the uterus and cervix, for a benign reason such as fibroids or heavy bleeding, routine cervical screening is generally no longer needed, according to the Mayo Clinic. There is no cervix left to screen, and no cancer history to monitor. The NHS similarly removes people from the invitation list in this situation.

After a subtotal (supracervical) hysterectomy, the cervix stays in place, and so does your screening schedule. Some people are genuinely unsure which operation they had; it’s written in your surgical records, and it’s worth confirming rather than assuming, because “I had a hysterectomy” gets treated as a reason to stop when sometimes it shouldn’t be.

The other exception is history. If the hysterectomy was performed because of cervical cancer or significant pre-cancerous changes, or if you had such changes in the years before surgery, clinicians usually continue periodic sampling from the top of the vagina (the vaginal vault) for some years afterward. The interval and duration are individualized: this is follow-up care, not population screening, and it belongs to your treating team.

The practical takeaway: after any hysterectomy, ask the surgeon one direct question before discharge, “Do I still need cervical screening, and if so, on what schedule?”, and get the answer in writing.

What happens if your result is abnormal, does your interval change?

It changes immediately, and that’s the system working, not failing. An abnormal screening result is common and is not a cancer diagnosis: a point Cleveland Clinic makes emphatically, since the anxiety these letters cause is often wildly out of proportion to what they mean.

In an HPV-first program like the NHS, the branching goes like this, per the NHS:

  • HPV found, cells normal: no treatment, but you’re recalled in 12 months instead of five years, to check whether your immune system has cleared the virus, as it usually does.
  • HPV found, cell changes present: referral for colposcopy, a magnified look at the cervix, where a specialist decides whether changes need monitoring or removal.
  • HPV still present at repeat tests: continued annual checks, with colposcopy if the virus persists over successive years.

US pathways are similar in spirit: minor abnormalities often mean a repeat test in about a year, while higher-grade changes or persistent HPV go to colposcopy. After treatment for significant cell changes, follow-up testing is more frequent for several years before you return to routine intervals.

Two reassurances backed by the biology. Most HPV infections clear without any intervention, per the CDC. And when cell changes do need removing, treatment of pre-cancerous changes is precisely how screening prevents cancer: the whole program is built to reach this moment early, when the fix is minor.

Who might need smear tests more often than the standard interval?

The intervals in this article are population defaults. Several situations move people onto a faster, individualized schedule set by their clinician:

  • A weakened immune system. People living with HIV, organ transplant recipients, and others on long-term immune-suppressing treatment clear HPV less reliably, and the WHO notes cervical cancer can develop faster in this group, in as little as five to ten years rather than 15 to 20. More frequent screening, sometimes starting earlier, is standard.
  • Previous treatment for cervical cell changes. Post-treatment surveillance runs on shorter cycles for several years, and may extend beyond the usual stopping age.
  • A recent HPV-positive result, which triggers annual recall rather than the routine gap, as described above.
  • Prenatal DES exposurerelevant to a small, mostly older group whose mothers took a synthetic estrogen decades ago, historically warranted closer surveillance; the CDC lists it among reasons screening advice may differ.

Pregnancy, on the other hand, usually slows things down rather than speeding them up. Routine screening that falls due during pregnancy is generally deferred; the NHS typically suggests waiting until around 12 weeks after birth, since pregnancy changes the cervix and can muddy results. If you had an abnormal result before conceiving, follow-up may still proceed during pregnancy: that call belongs to your care team, not the standard timetable.

Which symptoms should never wait for your next smear test?

This may be the most important section in the article, so let’s be blunt: screening is for people with no symptoms. If your body is already signaling, the five-year calendar is irrelevant: you need an appointment now, whatever your last result said and however recently you were tested.

See a doctor promptly for any of the following, which MedlinePlus and the NHS flag as reasons for assessment rather than routine screening:

  • Bleeding between periods, after sex, or any bleeding after menopause
  • Vaginal discharge that is persistent, blood-tinged, or unusual for you
  • Pain during sex, or ongoing pelvic or lower-back pain without an obvious cause
  • Periods that have become suddenly and markedly heavier or longer

Most of the time these symptoms have benign explanations, infections, hormonal shifts, cervical polyps, fibroids. That’s genuinely reassuring, but it’s a conclusion a clinician reaches after examining you, not one to assume from a recent normal screen. A smear test taken while you have symptoms isn’t the right investigation anyway; symptomatic patients get an examination and targeted tests instead.

The pattern to internalize: a normal result five months ago is not a force field, and an upcoming invitation is not a reason to wait. Screening finds silent changes; symptoms have already broken the silence.

Missed a smear test, or dreading the next one?

First, the missed appointment. Being overdue is common, fixable, and carries no penalty: in the UK you can book with a GP surgery at any point after your invitation, and in the US you simply schedule with your clinician. The test performed late works exactly as well as the test performed on time: the risk lives in the gap stretching from months into years. If it’s been so long you’ve lost track, say so; nobody in the room will be surprised, and clinicians would far rather see a ten-years-overdue patient than not see them at all.

Second, the dread, which is real, whether it stems from discomfort, embarrassment, past trauma, or menopause-related changes that make the exam physically harder. Practical adjustments genuinely help, and you’re entitled to ask for all of them: a smaller speculum, a female clinician, extra time, a chaperone or companion, and stopping at any point you say so. The Mayo Clinic also advises avoiding intercourse and vaginal products for a couple of days beforehand, and booking outside your period, so the sample is as readable as possible, one less chance of a repeat visit.

Change is coming for the most reluctant attendees: several countries, including parts of the UK and the Netherlands, now offer or are piloting HPV self-sampling kits you use at home. Ask what’s available where you live. A test you’ll actually take beats a perfect test you keep postponing.

The bottom line: attendance beats perfect timing

Strip away the national differences and one fact towers over the rest: cervical cancer is among the most preventable of all cancers, and screening is the reason. The WHO counted around 660,000 new cases and roughly 350,000 deaths worldwide in 2022, and the overwhelming majority occurred in places without organized screening programs. Where invitations go out and people answer them, this disease has become steadily rarer.

So the honest editorial opinion, grounded in that evidence: don’t agonize over whether three years or five is “safer.” Both schedules were built by people who studied the biology, the slow 15-to-20-year march from persistent HPV to cancer, and matched the test’s sensitivity to the disease’s speed. The three-year Pap and the five-year HPV test land in roughly the same place. The person at genuine risk isn’t the one on the “wrong” national schedule; it’s the one on no schedule at all. Unscreened and under-screened people account for a large share of cervical cancers in every country that has looked.

Your to-do list is short. Know which system you’re in and when your next test is due. Book it when invited, or book it now if you’re overdue. Report bleeding or discharge symptoms without waiting. And if your circumstances are non-standard, immunosuppression, past cell changes, a hysterectomy, get your personal schedule from your clinician in plain words, and write it down where the group chat can’t confuse it.

Frequently asked questions

How often do you need a smear test in the UK?

Every five years between ages 25 and 64, across England, Scotland and Wales, provided HPV is not found in your sample. England extended its interval from three to five years for under-50s in July 2025, aligning with the rest of Britain. If HPV is found, you’re recalled after 12 months instead, and cell changes trigger a colposcopy referral rather than a routine wait.

How often is a Pap smear needed in the US?

Every three years from ages 21 to 29 using a Pap test alone. From 30 to 65, CDC-reflected guidelines offer three options: a Pap every three years, a high-risk HPV test every five years, or both together every five years. All three are considered effective. Your clinician will recommend one based on your history and which tests the practice’s lab performs.

Why are smear tests every 5 years now instead of 3?

Because the test changed, not the caution level. HPV primary screening detects the virus that causes nearly all cervical cancers and is more sensitive than examining cells alone. A negative HPV result predicts very low risk for years, since the WHO notes cancer typically takes 15 to 20 years to develop from persistent infection. Testing more often mainly catches harmless, transient infections.

At what age should you have your first smear test?

At 25 in the UK, the NHS invitation can arrive up to six months before your birthday, and at 21 in the US. Most European programs start between 25 and 30. Screening isn’t offered earlier because HPV infections in the late teens and early twenties are extremely common and usually clear on their own, while cervical cancer at those ages is rare.

When can you stop having smear tests?

At 64 in the UK and 65 in the US, but only with an adequate recent history of normal results. The CDC’s framework generally requires several consecutive negative tests within the past decade, the most recent within five years, and no history of significant cell changes. If you’ve been out of screening for years, one catch-up test before stopping is the safer route.

Do you need smear tests if you've had the HPV vaccine?

Yes, on the same schedule as unvaccinated people. The vaccine protects against the highest-risk HPV types but not all of them, and it can’t clear infections acquired before vaccination. Screening catches the exceptions early. Researchers are studying whether heavily vaccinated generations might eventually need fewer lifetime tests, but no program has changed intervals for vaccinated people yet.

Do you need smear tests after a hysterectomy?

Usually not after a total hysterectomy for a benign condition, because the cervix has been removed. You do still need screening if you had a subtotal hysterectomy that left the cervix in place, and you’ll likely need continued vault sampling if the surgery involved cervical cancer or significant pre-cancerous changes. Confirm which operation you had and get your surgeon’s screening advice in writing.

Can you have a smear test while pregnant?

Routine screening due during pregnancy is usually postponed: the NHS typically suggests waiting until about 12 weeks after birth, since pregnancy changes the cervix and can make results harder to interpret. Follow-up for a pre-existing abnormal result is different and may go ahead during pregnancy under specialist guidance. Tell the booking clinician you’re pregnant so the timing can be adjusted.

Do you need smear tests if you're not sexually active or have same-sex partners?

Yes, once you reach the starting age. HPV spreads through any skin-to-skin genital contact, including between women, so same-sex partners carry real risk and should screen on the standard schedule. People who have never had any sexual contact are at very low risk, and the NHS notes screening is a personal choice in that situation, worth discussing with a GP rather than skipping silently.

What does an HPV-positive smear test result mean?

It means the virus was found, not that you have cancer, and not necessarily that anything is wrong with your cells. Most HPV infections clear on their own within about two years, per the CDC. With normal cells, you’ll simply be re-tested in 12 months. With cell changes, you’ll be referred for colposcopy, where a specialist decides whether monitoring or minor treatment is needed.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published October 19, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.